166 related articles for article (PubMed ID: 25800827)
1. Mycophenolate mofetil in primary central nervous system vasculitis.
Salvarani C; Brown RD; Christianson TJ; Huston J; Giannini C; Miller DV; Muratore F; Hunder GG
Semin Arthritis Rheum; 2015 Aug; 45(1):55-9. PubMed ID: 25800827
[TBL] [Abstract][Full Text] [Related]
2. Long-term remission, relapses and maintenance therapy in adult primary central nervous system vasculitis: A single-center 35-year experience.
Salvarani C; Brown RD; Christianson TJH; Huston J; Giannini C; Hunder GG
Autoimmun Rev; 2020 Apr; 19(4):102497. PubMed ID: 32062032
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil as induction and maintenance immunosuppressive therapy in adult primary central nervous system vasculitis: A prospective observational study.
Das S; Goswami RP; Sinha D; Shobhana A; Purkayastha S; Datta A
Clin Rheumatol; 2023 Aug; 42(8):2155-2162. PubMed ID: 37069367
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
Hu W; Liu C; Xie H; Chen H; Liu Z; Li L
Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
[TBL] [Abstract][Full Text] [Related]
5. Treatment of primary angiitis of the central nervous system in childhood with mycophenolate mofetil.
Sen ES; Leone V; Abinun M; Forsyth R; Ramesh V; Friswell M; O'Callaghan F; Ramanan AV
Rheumatology (Oxford); 2010 Apr; 49(4):806-11. PubMed ID: 20100791
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
Li X; Ren H; Zhang Q; Zhang W; Wu X; Xu Y; Shen P; Chen N
Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733
[TBL] [Abstract][Full Text] [Related]
7. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Li X; Tian J; Wu J; He Q; Li H; Han F; Li Q; Chen Y; Ni Q; Chen J
Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
[TBL] [Abstract][Full Text] [Related]
8. Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
Wang J; Hu W; Xie H; Zhang H; Chen H; Zeng C; Liu Z; Li L
Lupus; 2007; 16(9):707-12. PubMed ID: 17728363
[TBL] [Abstract][Full Text] [Related]
9. Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide.
Stassen PM; Tervaert JW; Stegeman CA
Ann Rheum Dis; 2007 Jun; 66(6):798-802. PubMed ID: 17179175
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
Lourdudoss C; Vollenhoven Rv
Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.
Jones RB; Hiemstra TF; Ballarin J; Blockmans DE; Brogan P; Bruchfeld A; Cid MC; Dahlsveen K; de Zoysa J; Espigol-Frigolé G; Lanyon P; Peh CA; Tesar V; Vaglio A; Walsh M; Walsh D; Walters G; Harper L; Jayne D;
Ann Rheum Dis; 2019 Mar; 78(3):399-405. PubMed ID: 30612116
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
[TBL] [Abstract][Full Text] [Related]
13. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
Zhu B; Chen N; Lin Y; Ren H; Zhang W; Wang W; Pan X; Yu H
Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis.
Koukoulaki M; Jayne DR
Nephron Clin Pract; 2006; 102(3-4):c100-7. PubMed ID: 16286784
[TBL] [Abstract][Full Text] [Related]
16. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
Dittrich K; Ross S; Benz K; Amann K; Dötsch J
Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil in anti-MPO renal vasculitis: an alternative therapy in case of cyclophosphamide or azathioprine toxicity.
Ibernon M; Poveda R; Vidaller A; Bestard O; Grinyó JM
Clin Nephrol; 2008 Jun; 69(6):395-401. PubMed ID: 18538114
[TBL] [Abstract][Full Text] [Related]
18. Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients.
Salvarani C; Brown RD; Christianson TJ; Huston J; Giannini C; Miller DV; Hunder GG
Arthritis Rheumatol; 2015 Jun; 67(6):1637-45. PubMed ID: 25708615
[TBL] [Abstract][Full Text] [Related]
19. The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch-Schönlein purpura nephritis.
Ren P; Han F; Chen L; Xu Y; Wang Y; Chen J
Am J Nephrol; 2012; 36(3):271-7. PubMed ID: 22965140
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Primary Angiitis of the Central Nervous System.
Bays AM
Neuroimaging Clin N Am; 2024 Feb; 34(1):23-29. PubMed ID: 37951702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
